Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C

Author： Belon Craig A   Frick David N  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.4, Iss.3, 2009-05, pp. : 277-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiviral therapy reduces HRQOL in patients with hepatitis C

By  

Reactions Weekly, Vol. 1, Iss. 1100, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Pentacyclic compounds useful as inhibitors of hepatitis C virus NS3 helicase

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1777-1779

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Pegylated Interferon Antiviral Therapy of Chronic Hepatitis C

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 5, Iss. 4, 2006-10 ,pp. : 379-387

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms Involved in the Development of Chronic Hepatitis C as Potential Targets of Antiviral Therapy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1774-1780

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatitis C virus: quasispecies dynamics, virus persistance and antiviral therapy

By Cristina Juan  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 499-510

Informa Healthcare

Access to resources Recommend Favorite